Ovarian Cancer

In this episode, host Shikha Jain, MD, speaks with Kimberly Richardson about driving changes in patient advocacy efforts, the importance of including DEI in cancer research and clinical trials and more.

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for direct-to-consumer products, according to a medical oncologist with expertise in cancer genetics.

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in the part of the gene that is central to BRCA2 function, according to study results.

Early receipt of palliative care appeared linked to less aggressive end-of-life care for women with ovarian cancer, according to study results.

As 2024 comes to a close, Healio is pleased to present our most widely read oncology and hematology content from the past 12 months.

Endometrial cancer has become the number one cancer diagnosis among U.S. women, particularly among the younger population, with nearly 68,000 cases and 14,000 deaths expected annually, according to Robert Wenham, MD.

Laparoscopy may offer perioperative advantages to laparotomy and may be an acceptable alternative for some women with ovarian cancer, but systematic review and meta-analysis findings are limited by inclusion of only observational studies.

CHICAGO — Patients treated with mirvetuximab require close follow-up with an ophthalmologist due to the potential for corneal toxicity, according to a study.

Self-identifying transgender individuals assigned female at birth face three key barriers when seeking care for breast or gynecologic cancers, according to results of a qualitative study published in JAMA Network Open.

Adults with Graves’ disease treated with antithyroid drugs have a higher risk for multiple types of cancer compared with the general population, according to findings published in Thyroid.